ENH split aim 2 into a and b

This commit is contained in:
Nathan Dwarshuis 2021-07-25 23:11:30 -04:00
parent 436eccc733
commit 5b6c4bed54
1 changed files with 11 additions and 4 deletions

View File

@ -478,9 +478,9 @@ cells compared to state-of-the-art beads using \invivo{} mouse models for
In Chapter~\ref{background}, we provide additional background on the current In Chapter~\ref{background}, we provide additional background on the current
state of T cell manufacturing and how the work in this dissertation moves the state of T cell manufacturing and how the work in this dissertation moves the
field forward. In Chapters~\ref{aim1},~\ref{aim2}, and~\ref{aim3} we present the field forward. In Chapters~\ref{aim1},~\ref{aim2a},~\ref{aim2b}, and~\ref{aim3}
work pertaining to Aims 1, 2, and 3 respectively. Finally, we present our final we present the work pertaining to Aims 1, 2, and 3 respectively. Finally, we
conclusions in Chapter~\ref{conclusions}. present our final conclusions in Chapter~\ref{conclusions}.
\chapter{background and significance}\label{background} \chapter{background and significance}\label{background}
\section*{background} \section*{background}
@ -1545,7 +1545,14 @@ immunotherapies are activated and expanded with either soluble mAbs or
bead-immobilized mAbs, our system will likely serve as a drop-in substitution to bead-immobilized mAbs, our system will likely serve as a drop-in substitution to
provide these benefits. provide these benefits.
\chapter{aim 2}\label{aim2} \chapter{aim 2a}\label{aim2a}
\section{introduction}
\section{methods}
\section{results}
\section{discussion}
\chapter{aim 2b}\label{aim2b}
\section{introduction} \section{introduction}
\section{methods} \section{methods}